Abstract. We have investigated the expression of integrins by rat oligodendroglia grown in primary culture and the functional role of these proteins in myelinogenesis. Immunochemical analysis, using antibodies to a number of ot and/3 integrin subunits, revealed that oligodendrocytes express only one detectable integrin receptor complex (CtO~OL). This complex is immunoprecipitated by a polyclonal anti-human/~ integrin subunit antibody. In contrast, astrocytes, the other major glial cell type in brain, express multiple integrins including c~1/~, ~3/~1, and cts/~l complexes that are immunologically and electrophoretically indistinguishable from integrins expressed by rat fibroblasts. The/3 subunit of the oligodendrocyte integrin (/3OL) and rat fibroblast/~1 have different electrophoretic mobilities in SDS-PAGE. However, the two/3 subunits appear to be highly related based on immunological cross-reactivity and one-dimensional peptide mapping. After removal of N-linked carbohydrate chains, /3OL and/~ comigrated in SDS-PAGE and peptide maps of the two deglycosylated subunits were identical, suggesting differential glycosylation of/31 and/3OL accounts entirely for their size differences. The oligodendrocyte oL subunit, O~OL, was not immunoprecipitated by antibodies against well characterized o~ chains which are known to associate with 13~ (o~3, ou, and Ors). However, an antibody to o~s, a more recently identified integrin subunit, did precipitate two integrin subunits with electrophoretic mobilities in SDS-PAGE identical to CXOL and /3OL. Functional studies indicated that disruption of oligodendrocyte adhesion to a glial-derived matrix by an RGD-containlng synthetic peptide resulted in a substantial decrease in the level of mRNAs for several myelin components including myelin basic protein (MBP), proteolipid protein (PLP), and cyclic nucleotide phosphodiesterase (CNP). These results suggest that integrin-mediated adhesion of oligodendrocytes may trigger signal(s) that induce the expression of myelin genes and thus influence oligodendrocyte differentiation.
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M
YELINATION is a major developmental process of the nervous system, carried out by oligodendroglia in the central nervous system (CNS)? and Schwann cells in the peripheral nervous system (PNS). Myelin is a membranous sheath that is an extension of the plasma membrane of the myelin producing cell. It consists of numerous alternating lipid and protein-containing lameUae wrapped tightly around a segment of neuronal axon, functioning as an insulator to.accelerate the velocity of electrical impulses transmitted between a neuronal cell body and its target cell (Raine, 1984) . The brain also contains numerous pr0cess-bearing cells including neurons that are not myelinated. Lit-fie is known about the biochemical processes underlying specific recognition between oligodendroglia and their neuronal targets and/or their surrounding extracellular matrix (ECM). Adhesion events are likely to be critical in determining the ability of oligodendroglia to form myelin. A number of adhesion molecules have been suggested to take part in myelination. In Schwann cells myelin-associated glycoprotein (MAG) and L1 have been implicated (for review see Quarles, 1989) . In neurons, L1 and N-CAM are likely to be involved (Nieke and Schachner, 1985; Martini and Schachnet, 1986) .
In addition to cell-cell interactions it is now evident that cell-matrix interactions play a significant role in development. Integrins are a family of cell surface receptors which translate signals outside the cell to alterations in cell behavior. A role for integrins and ECM in leukocyte development (for review see Heraler, 1990 ) and in neural development and migration (for review see Reichardt and TomaseUi, 1991) has been clearly demonstrated. Integrins bind certain components of the extracellular matrix, mainly glycopro-teins such as fibronectin, laminin, and vitronectin (for review see Hynes, 1987; Ruoslahti and Pierschbacher, 1986) . The integrins were originally classified into three major subfamilies (/3~, /32, and/33) each having a common/3 subunit noncovalently associated with a distinct set of a subunits (Hynes, 1987) . In addition to these three well characterized /3 subunits, there have been five other/3 subunits reported including/34 (Kajiji et al., 1989; Suzuki and Naitoh, 1990; Hogervorst et al., 1990) , /35 (Ramaswamy and Hernler, 1990; McLean et al., 1990) ,/36 (Sheppard et al., 1990) ,/37 (Yuan et al., 1992; Erie et al., 1991) , and/3s (Moyle et al., 1991) . It has also been shown that some ot subunits can associate with more than one/3 subunit and therefore there is no longer a clear demarcation between subfamilies (Cheresh et al., 1989; Kajiji et al., 1989; Vogel et al., 1990; Krissansen et al., 1990; Dedhar and Gray, 1990) .
Some integrins (e.g., the fibronectin receptor) recognize the tripeptide sequence RGD (Arginine-Glycine-Aspartic Acid) which appears to play a key role in cell adhesion (for review see Ruoslahti and Pierschbacher, 1987) . Our laboratory previously reported that isolated oligodendrocytes are able to bind to components of a matrix derived from glial cells in culture via a protein which appeared to have integrinlike binding properties (Cardwell and Rome, 1988a) . In this report we have investigated the biochemical nature of this protein and present direct evidence that it is a member of the integrin superfamily. In addition, this receptor appears to play a regulatory role in CNS myelination.
Materials and Methods

Cell Culture and Astroglial Matrix Preparation
Purified oligodendrocytes were prepared from neonatal rat cerebral cortex after the method of McCarthy and de Vellis (1980) with modifications (Rome et al., 1986; Cardwell and Rome, 1988a) . Two days after isolation, greater than 80% of the cells stain positively for the oligodeodrocyte marker, galactocerebroside, and most cells that score as negative for gaiactocerebroside possess oligodendrocyte morphology, and, in the presence of 5 % calf serum-containing medium, go on to express galactocerebroside with time in culture (Cardwell and Rome, 1988a) . Astroglial matrix (AGM) was prepared as described earlier (Rome et al., 1986; Cardwell and Rome, 1988a) . Briefly, mixed glial cells were cultured in 100-ram tissue culture plates and grown to confluence. Media was then removed and 10 ml of distilled water was added to each plate. After 2 h or longer incubation at room temperature, the lysed cell material was removed. The plates were washed two times with PBS, once with serum-free medium, and stored in medium at 37°C until use. The material remaining on the culture surface after water lysis is referred to as AGM (astroglial matrix). Typical AGM contained 0.5-1 /~g protein per cm 2 surface.
We use the term equivalent "brain age ~ to mean the days in culture plus the age of the rat pups at the time of dissection (2 d in these studies). Isolated oligodendrocytes (10-12 d equivalent brain age) were either used for surface labeling or plated onto AGM-coated tissue culture plates and maintained in DMEM/FI2 (1:1) containing Hepes (15 raM, pH 7.1), NaHCO3 (1.2 g/l), and 5 % calf serum (Hyclone, Logan, UT) for RNA preparation. Astrocytes, prepared by the method of McCarthy and de Vellis (1980) , were maintained in DMEM/F12 as above. Rat and human skin fibroblasts were established in our laboratory and cultured in low glucose DMEM medium supplemented with 10% calf serum.
Cell Surface labeling and Immunoprecipitation
For surface-labeling, oligodendrocytes from 80 cortices (from 40 neonatal rat pups) were removed from mixed glial cells by overnight shaking (McCarthy and de Vellis, 1980) and pelleted by brief centrifugation in a table-top centrifuge at 450 g. The pellet (5 x 107 cells) was washed twice with PBS by resuspension and centrifugation and the final pellet was suspended in 1 ml PBS containing 1 mM Ca ++ and 1 mM Mg ++. Astrocytes (108 cells) and fibroblasts (5 × 107 cells) were removed from flasks by incubating in 20 mM EDTA in PBS (2 ml per flask) for 10--20 rain. Detached cells were collected in PBS containing 1 mM each Ca ++ and Mg ++ and pelleted by centrifugation at 450 g. Cells were washed three times and resnspended in 1 ml of the same buffer. Iodination of the cells was performed using the iodogen method (Markwell and Fox, 1978) . Surfaceiodinated cells were extracted on ice with "Iris buffer (100 m_M Tris-HC1, 0.15 M NaC1, 0.5 mM MgCI2.6H20) pH 7.2, containing 0.5% NP-40, 0.1% aprotinin, 1 mM PMSF, and 1 t~M pepstatin A (Sigma Chem. Co., St. Louis, MO). The extracts were clarified by centrifngation at 14,000 g for 15 rain followed by incubation with non-immune rabbit or mouse serum and protein A-Sepharose beads (anti-mouse IgG-agarose for mouse serum). Integrin heterodimers were then immunoprecipitated using one or more of the following polyclonal antibodies raised aom~inst either an intact integrin subuuit (anti-/~O, or a synthetic peptide of the cytoplasmic domain (anti-t3, anti-fls, anti-c~s, anti-o~, anti-as, anti-c~s, anti-co anti-c~v subunits) or a monoclonal antibody (anti-c~7). The antibodies were generous gifts of Dr. Martin Hemler (anti-fib anti-fls, anti-cu,), Dr. Richard Hynes (anti-t3, anti-ct3, and anti-ors), Dr. Stephen Kaufman (anti-OfT), Drs. Lynn Sehnapp and Robert Pytela (anti-ors), Dr. Dean Sheppard (anti-~xg), and Dr. Louis Reicbardt (anti-o~v). The immune complexes were recovered with protein A-Sepharose or anti-mouse IgG-Agarose. After extensive washing, immune complec, es were dissociated from the beads by boilinE in sample buffer (2% SDS, 100 mM Tris-HCl, pH 6.8, 10% glycerol, 10 mM EDTA). Samples were analyzed by SDS-PAGE using 4% and 6% acrylamide in the stacking and running gels, respectively (Laemmli, 1970) . Gels were then dried, and exposed to Kodak XAR-5 film to visualize labeled integrin summits. All immunoprecipitation results were confirmed by a minimum of three repeat experiments.
Treatment of lntegrins with N-Glycanase F
Oligodendrocyte and fibroblnst integrim were immunopreeipitated using anti-ill antibody as described above. Immunoprecipitated protein was denatured by boiling in 1% SDS for 3 rain. Sodium phosphate buffer (20 raM, pH 7.2) containin~ 10 ~ sodium azide, 50 mM EDTA, alKl 0.5% n-octylglucoside was then added to bring the SDS concentration to 0.1% and the samples boiled again for 3 rain. After cooling, N-glycosidase F (0.5 unit; Boehringer Mannheim Corp., Ivdianapolis, IN) was added to each sample followed by incubation for 16 h at 370C before analysis on SDS-PAGE.
Northern Blot Analysis
Oligodendrocytes (10 d equivalent brain age) were plated onto 150-mm tissue culture plates coated with AGM (see above). At 17 d equivalent brain age, select cultures were treated for a period of 48 h with 0.1 mg/ml GRGDSP peptides, or 0.1 mg/ml GRGESP peptides, or 0.1 ~g/ml eycloheximide, or0.1 mg/ml GRGDSP + 0.1 ttg/ml cycloheximide. Total RNA was prepared by the method of Chomczynski and Sacchi (1987) using acid guanidinium thiocyanate-phenol-chloroform extraction. For developmental studies, isolated oligodendmcytes were plated in 150-mm tissue culture plates and RNA was prepared from each culture at various stages of development. The earliest time point was at day 13 and the latest was at day 23 (equivalent brain age). RNA separation was carried out on 1.0% agarose/ formaldehyde gels before transfer to nylon membranes (ICN Biotrans). Blots were prehybridized in 50% formamide, 0.2% SDS, 5x Denbardt's, 5x Pipes, and 10/~g/ml salmon sperm DNA overnight at 42°C. Hybridization probes (myelin basic protein [MBP] , proteolipid protein [PIP] , and cyclic nucleotide phosphodiesterase [CNP] and human fll integrin, generous gifts of Drs. Anthony Campagnoui, Robert Milner, Sally Lewis, and Erkki Ruoslahti, respectively) were labeled with [a-32p]dCTP to a specific activity of ,ol.2 × 109 cpm/tLg by the random priming method (BRL). Hybridization was carried out overnight at 420C in the same solution as prehybridization buffer except Denhardt's was used at lx and salmon sperm DNA was added to 100 ttg/rul. After hybridization, blots were washed two times (1 h each) in 2× SSC containing 0.2% SDS for 1 h at 420C followed by a third wash in 2x SSC, containing 0.2% SDS at 56°C for 1 h and exposed to Kodak XAR-5 film. To normalize for the amount of RNAs loaded in each well, blots were stripped and reprobed for chicken fl-actin (Cleveland et al., 1980) . Autoradiographs were scanned with an Ultrascan XL laser densitometer (Pbarmacia LKB Biotechnology, Piscataway, NJ) and analyzed with the GelScan XL 2.1 software package (Pharmacia LKB).
Figure L Immunoprecipitation from surface-iodinated fibroblasts (.4, lanes 1, 3, 5, and 7), oligodendrocytes (A, lanes 2, 4, 6, and 8; B, lanes 1 and 2), and astrocytes (C, lanes 1-3) using antibodies to c~5, ill, a3, and cts integrin subunits as well as preimmune control antibody (PI) as indicated on the figure. The experiments in A and C represent sequential immunoprecipitations on each cell extract using the indicated antibodies. The precipitates were analyzed under nonreducing conditions by SDS-PAGE. The three panels represent three different SDS gels; however, the positions of the integrin chains have been labeled consistently thronghout with respect to molecular weight standards on each gel.
Results
Immunochemical Analysis
To demonstrate directly the existence of integrins on the surface of rat oligodendrocytes, surface iodinated cells were solubilized and immunoprecipitated using antibodies to various integrin subunits. Antibodies specific for two different ct chains (tx3, and as) and three different ~ chains (/3,,/33, and 135) were initially tested. Only one antibody, anti-/31, gave a positive reaction with the labeled oligodendrocytes. In contrast, anti-or3, as, and/3, were all able to precipitate integrin subunits from detergent-solubilized surface labeled rat fibroblast samples run in parallel as a control. As indicated in Fig. 1 A, under non-reducing conditions, antiserum to a peptide representing the cytoplasmic domain of the human or5 integrin subunit coprecipitated an as and an associated /31 chain from surface-iodinated fibroblasts ( Fig. 1 A, lane /) while the same antiserum failed to detect any immunoreactive material in the detergent solubilized extract of surface-iodinated oligodendrocytes ( Fig. 1 A, lane 2) . Similarly, antiserum to a peptide representing the cytoplasmic domain of chicken et3 integrin subunit immunoprecipitated an or3 and associated/31 from fibroblasts ( Fig. 1 A, lane 5) . However this antiserum also failed to detect any immunologically cross-reactive protein in the oligodendrocyte lysate ( Fig. 1 A, lane 6) . In contrast, antiserum against human/3, integrin coprecipitated two polypeptides, a putative/3 and an associated ot subunit from oligodendrocytes ( Fig. 1 A, lane  4) ; we will refer to these polypeptides as aoL and/3OL (OL, for oligodendrocytes). The /3OL subunit had lower electrophoretic mobility in SDS-PAGE under non-reduced conditions ( Fig. 1 A, lane 4) than/31 from fibroblasts ( Fig. 1 A,  lanes 3 and 5) . In addition, oligodendrocytes maintained for two weeks in culture expressed this same arrangement of integrin chains (aOL and/3OL), indicating that the pattern of integrin expression was unchanged between days 12 and 21 equivalent brain age.
As mentioned above, we also tested the possibility of expression by oligodendrocytes of other/3 subfamily integrins such as ~5 and/~3. Both antibodies failed to detect any immunoreactive material in the oligodendrocytes lysate (data not shown). In addition, we examined whether the OtOL chain could be ix4, or t~v two other subunits that have been reported to associate with ~1 (Hemler et al., 1987; Vogel et al., 1990) . Both anti-or4 and Otv antibodies were found to be unreactive with the surface-labeled oligodendrocyte extracts (data not shown). While this work was in process, we obtained antibodies raised against integrin subunits txT, (Song et al., 1992) , or8 (L. Schnapp and R. Pytela, personal communication), and or9 (Palmer et al., 1993) , the more recently identified t~ subunits that appear to associate with a ~ chain. Immunoprecipitation of an nSI-labeled extract of oligodendrocytes using the above antibodies showed that only the a8 antibody reacted with the labeled extract (Fig.  1 B) . Two polypeptides were precipitated, a putative c~ that has a smaller size from that reported for chick a8 (Bossy et al., 1991) and an associated/3 subunit ( Fig. 1 B, lane/) . The protein doublet immunoprecipitated with anti-ors had a mobility in SDS-PAGE identical to the doublet immunoprecipitated with anti-/31 (tXOL, /3OL) ( Fig. 1 B, lanes 1 and 2,  respectively) suggesting that CeOL could be c~8 or an asrelated subunit.
Expression of integrins by rat astrocytes, the other major glial cell type in the CNS, was also examined using some of the same antibodies as above to immunoprecipitate extracts of surface-iodinated cells. An antibody to the cts integrin subunit coprecipitated and an oe and an associated/3 subunit ( Fig. 1 C, lane/) . The position of migration of these two bands corresponds to or5 and/31 from rat fibroblasts (Fig. 1  A, lane/) . Similarly, antibody to a3 integrin coprecipitated (Fig. 1 C, lane 3) with identical mobility to or3 and fl~ from rat fibroblasts (Fig. 1 A, lane 3 ). It appears that astrocytes express a relatively lower level of a3 compared to fibroblasts. Antibody to /3~ integrin also precipitated a fl subunit and associated oq, a3, and a5 chains ( Fig. 1 C, lane 2) . The fl~ subunit precipitated from astrocytes ran as a broad band (Fig. 1 C, lane 2) , this was likely due to both overloading and to the presence of a small amount of ~OL subunit which could arise from the ",,5 % oligodendrocyte contamination commonly seen in astrocyte preparations (this latter hypothesis was supported by repeat experiments on astrocytes where the lower molecular weight material was not observed).
Chemical Characterization of the Oligodendrocyte Integrin
The ~OL polypeptide was further compared to the putative fibroblast /31 chain by one dimensional peptide mapping (Cleveland et al., 1977) . Both integrin /3OL and/~ subunits yielded several identical peptide fragments (Fig. 2 A, compare lanes 1 and 2), as well as distinct fragments (Fig. 2 A, arrows). In the 18-30-Kd region, there are 2-3 fragments generated from the fibroblasts/3~ while in the same region /3OL produced only one peptide fragment that did not cornigrate with any of those from fibroblasts (see arrows). In the region below 14 Kd, the/3~ digest has an additional peptide that is missing in the ~OL digest (arrow). There was too little material from the t~OL sample to generate a distinct map.
To test whether differential glycosylation accounts for the differences in molecular weight and peptide maps of the fibroblast ~ and oligodendrocyte/3OL chains, the polypeptides were treated with N-glycanase F to remove N-linked carbohydrate chains. After digestion, the two/3 subunits ran as smaller proteins which comigrated in a non-reduced SDS gel (Fig. 2 B, lanes 3 and 4, B~ and/3oL, respectively, arrow). The ~ chains were also reduced in size but did not appear to run at identical mobilities. The deglycosylated 'Vog chain ran as a closely spaced doublet in this experiment, likely due to incomplete deglycosylation, since in other experiments only a single band at the lower size was seen (not shown). Peptide maps of the deglycosylated/3 chains were generated and found to be identical (Fig. 2 C) .
Developmental Expression of [3oL mRNA
The /~OL and /3~ subunits were also highly related at the mRNA level, Northern blots of total oligodendrocyte mRNA probed with a full-length eDNA specific for the human ~ integrin subunit, revealed a single 3.2-Kb message (Fig. 3, Figure 3 . Northern blot analysis of integrin/~ subunit message expressed by oligodendrocytes. Rat and human fibroblasts were used as control cells. Total mRNA from human fibroblasts 0ane 1, 10 #g), rat fibroblasts (lane 2, 10 #g) and rat oligodendrocytes 0ane 3, 30 #g) were prepared, transferred to a nylon membrane, and probed with a human/3~ integrin cDNA as described in Materials and Methods. lane 3). We used the human probe since to our knowledge, the rat ~1 has not been cloned. This message was approximately the same size as that seen in both human and rat fibroblast mRNA (Fig. 3, lanes 1 and 2, respectively) . We recently isolated a putative /3OL eDNA from an oligodendrocyte cDNA library (Malek-Hadayat, S., and L. H. Rome, manuscript in preparation). This clone shows >90% identity to mouse/31 eDNA and detects the same size oligodendrocyte mRNA in a Northern blot (not shown).
To examine whether expression of/3OL mRNA is developmentally regulated, total mRNA was prepared from isolated oligodendrocyte cultures at various developmental stages between day 13 (the earliest age at which we can obtain pure cells) and day 23 (a time beyond the peak period of myelin synthesis). The mRNAs were analyzed by Northern blots using the /~OL eDNA as a hybridization probe. Results shown in Fig. 4 A indicated no significant differences between the levels of mRNA expressed. This was confirmed by densitometric quantitation relative to /3-actin expression which was probed in the same gel (Fig. 4 B) .
Effect of GRGDSP Peptides and Cycloheximide on Expression of lntegrin and Myelin-Specific Messages by Oligodendrocytes
We have previously reported that GRGDSP synthetic peptides can block the initial attachment of oligodendrocytes to their substratum, AGM (Cardwell and Rome, 1988a) . However, the addition of GRGDSP peptides to established oligodendrocyte cultures does not cause cell detachment, yet these peptides significantly reduced the synthesis of MBP (Cardwell and Rome, 1988b) . To further analyze the mechanism of action of the GRGDSP peptides, we examined the effect of these peptides on the level of expression of mRNAs for several myelin genes, including MBP, CNP, and PLP. The results were compared to mRNA expression in the presence of a control non-specific peptide, GRGESE and normalized to expression of/~-actin. Cells grown in the presence of 0.1 mg/ml GRGDSP peptides showed a 74% reduction in * Purified oligodendrocytes were cultured on AGM alone (control) or treated for 48 h with GRGDSP, GRGDSP + cycloheximide, or cyeloheximide alone. Total mRNAs were extracted, separated on a 1% agarose gel (20/zg per well) and transferred to a nylon membrane. The membrane was sequentially probed with 32P-labeled MBP, PLP, and B-actin cDNAs as described in Materials and Methods. * Values were calculated from densitometric scans and normalized to the relative density of B-actin.
the amount of MBP mRNA relative to untreated control cells (Fig. 5, A and B, MBP, lanes 2 and 1, respectively) . In rat, PLP message is expressed as two different species of 1.6 and 3.2 Kb, both messages were reduced by •64 % compared to control (Fig. 5, A and B, PLP, lanes 2 and 1, respectively). Similarly, the CNP mRNA was decreased by ,x,40% relative to control (Fig. 5, A and B, CNP, lanes 2 and 1, respectively). In contrast, the control peptide, GRGESP, showed no significant inhibitory effect on expression of any of the myelin genes (Fig. 5 , third lane for each probe). In all experiments the level of peptide added (0.1 mg/mi) did not result in a significant detachment of cells from the culture substratum (less than 3 % of the cells detached). The effect of RGDcontaining peptides on expression of/3OL waS alSO examined. In contrast to the myelin genes, Northern blot analysis showed that RGD-containing peptides had no effect on the level of this putative /3OL mRNA (Fig. 5, A and B as indicated), which supports the selective regulation of myelin genes by RGD-containing peptides. Inhibition by RGD-containing peptides could be a direct effect on transcription of myelin genes or the peptides could be acting indirectly, perhaps by affecting genes encoding intermediary acting factors. To differentiate these two mechanisms, we treated cells with GRGDSP in the presence of cycloheximide (Table I) . Cycloheximide blocked the GRGDSP inhibition to a significant extent, allowing maintenance of MBP, and PLP messages near the control levels. Cycloheximide alone did not super-induce message for either of the myelin proteins (Table I) .
Discussion
In this study we have described the expression of a single integrin receptor complex by rat cerebral cortex oligodendroglia, a cell type restricted to the central nervous system and responsible for the synthesis of CNS myelin. Evidence presented here indicate that this integrin is an alternately glycosylated member of the/3~ subfamily. Preliminary resuits suggest that the associated ot subunit is cxs, however, definitive proof will require additional chemical and/or molecular analysis.
In addition to the chemical characterization, we have also presented evidence for a potential regulatory role for this receptor in synthesis of myelin components. We previously reported that isolated oligodendroglia in prirnary culture interact specifically with matrix components derived from mixed glial cells. Moreover, a synthetic hexapeptide containing the RGD sequence disrupts this interaction and inhibits the synthesis of myelin components such as MBP and sulfatides by oligodendrocytes (Cardwell and Rome, 1988a,b) .
These results prompted us to study the nature of this interaction and its effect on myelination. Based on the RGD and divalent cation dependence of oligodendrocyte adhesion, we speculated that a likely candidate for the adhesion receptor could be a member of the integrin family of receptors for ECM proteins. In the present study we used antibodies raised against several ot and/3 integrin subunits to probe for the presence of an oligodendrocyte integrin. Rat fibroblasts were used as control cells since these cells are known to express a number of integrin chains including ot~/31, tx3/3~, and ors/31 (Malek-Hedayat and Rome, 1992 ). Of nine antibodies tested, only anti-/3t and anti-as were able to immunoprecipitate an integrin complex from oligodendrocytes. Furthermore, the complexes immunoprecipitated with both antibodies were strikingly similar to each other with respect to electrophoretic mobility on non-reduced SDS-PAGE. Using a similar battery of antibodies we found that astrocytes, the other major glial cell type in brain, express multiple integrin receptors including ~x~/31, ot3/3~, and txs/3~. This combination of integrin chains is also expressed in C6 glioma cells, a chemically induced tumor cell line from rat brain (MalekHedayat and Rome, 1992) . Using a monoclonal antibody (3A3), which recognizes an u~/3~ heterodimer, Tawil et al. (1990) previously demonstrated the presence of this integrin on the surface of rat astrocytes. Astrocytes from mouse can be stained with anti-fibronectin receptor antibodies (Pesheva et al., 1988) , which is consistent with our finding of o~5/3~ in rat astrocytes.
The oligodendroeyte integrin/3 subunit (/3OL) and the/31 subunit expressed by rat fibroblasts displayed different mobilities on non-reducing SDS-PAGE. However, peptide maps of the two subunits indicated that they were highly related. After removal of N-linked carbohydrate chains by N-glycanase F both subunits were found to comigrate on SDS gels. In addition, peptide maps of the two deglycosylated subunits were indistinguishable, suggesting that/30,, and/3~ are identical at the amino acid level and that differential glycosylation occurs in oligodendrocytes and fibroblasts. Due to the unique role of the oligodendrocyte integrin in regulation of myelin synthesis, it is possible that this cell-specific glycosylation may play a role in receptor function. A number of studies have recently attempted to examine the role of integrin carbohydrate chains on the adhesive properties and biological function of these receptors. During development, mouse T cells have been shown to express two different/3~ subunits that differ in the extent of N-linked glycosylation and sialylation. The differential glycosylation of the /3~ subunit appears to effect binding of the receptor to fibronectin (via VLA-4 and VLA-5) and laminin (via VLA-6) (Wadsworth et al., 1993) . The effect of an altered glycosylation of the fl~ subunit on binding of the cells to fibronectin and laminin has been shown as well by other investigators (Akiyama et al., 1989; Kawano et al., 1993; Diamond et al., 1991; Oz et al., 1989) . It remains to be determined whether the altered glycosylation of BoL, compared to its rat fibroblast homolog, plays a significant role in receptor function.
We have not characterized the OtoL subunit to the same extent as /~OL. It appears to be either expressed in lower abundance or less efficiently iodinated than /3oL. Our preliminary results using antibodies to a number of recently described a subunits suggest that aoL might be as since antibody raised against the cytoplasmic domain of human integrin a8 subunit immunoprecipitated two polypeptides from oligodendrocytes with the identical mobilities on SDS-PAGE as aOL~OL (Fig. 1 B) . However, attempts to produce definitive comparative peptide maps of aoL and as have been thus far unsuccessful.
The possibility that occupancy of the aot~oL integrin by RGD-containing peptides inhibits myelin synthesis by oligodendroglia suggests an important functional role for this receptor that may go beyond cell-substratum adhesion. There are now numerous examples in the literature where binding to extracellular matrix has been shown to regulate transcriptional activity and thus alter cellular differentiation. One of the first examples was in myoblasts, where anti-integrin antibodies were shown to prevent cell differentiation into myotubules (Menko and Boettinger, 1987) . We have added anti-/3, antibodies to isolated oligodendrocytes in an attempt to mimic the inhibition of myelination that results from addition of RGD-containing peptides. Three different anti-~ polyclonals have been tested without success. However, these function-blocking experiments are complex, requiring antibodies against native determinants at or near functional extracellular domains.
It is important to stress that the evidence we present here for a functional role of the oligodendrocyte ~,-related integrin in myelination is indirect. The evidence, presented here and in previous studies (Cardwell and Rome, 1988a,b) includes (a) the presence of a single detectable integrin receptor on oligodendrocytes using a wide variety of anti-or and /3 chain antibodies; (b) the specific inhibition of oligodendrocyte adhesion by RGD-containing peptides; and (c) the specific inhibition of myelin synthesis by these same peptides (including reduction in mRNAs for the major myelin components, and a reduction in the synthesis of myelin lipids and proteins). Without a function-blocking anti-integrin antibody or other direct data, one must exercise caution in concluding that the RGD effects on myelin synthesis are mediated through the oligodendrocyte integrin. However, we feel that this data supports the hypothesis that specific adhesion of oligodendrocytes to a glial-derived matrix via an integrin receptor regulates myelin gene expression and thereby plays a critical role in differentiation of oligodendrocytes into a myelinating phenotype. A dissection of the biochemical events that lead to such a regulatory response has yet to be carded out, however, based on the present results it is reasonable to hypothesize that an integrin-mediated adhesion of oligodendrocytes triggers signal(s) that directly or indirectly induce the expression of myelin genes. This hypothesis is supported by the observation that cycloheximide caused a significant reduction in the inhibitory effect of RGD peptides ( Table I ), suggesting that a new protein must be synthesized for the inhibition to occur. Cycloheximide is also known to selectively stabilize certain mRNAs, however, the absence of increased mRNA levels in the presence of cycloheximide alone, argues against this being the mechanism of cycloheximide action. Although it is still possible that RGD peptides cause myelin mRNAs to become unstable and that this instability is overcome by the addition of cycloheximide. The involvement of integrins in signal transduction is a relatively recently described phenomenon for which there is now increasing evidence (for review see Hynes, 1992) . For example, it has been reported that in human neutrophils Oaconi et al., 1991; Richter et al., 1990) and osteoclasts (Miyauchi et al., 1991) changes in intracellular Ca ++ occur in response to adherence of integrin receptors to matrix components, In addition other integrin-linked signaling events such as changes in cAMP levels (Nathan and Sanchez, 1990) , increased protein tyrosine phosphorylation (Kornberg et al., 1991) and protein kinase C-dependent cytoskeletal rearrangement (Pardi et al., 1992) have been reported. Involvement of integrins in regulation of gene expression in rabbit synovial fibroblasts has also been studied 0Verb et al., 1989) .
If the oligodendrocyte integrin we describe here does in fact regulate myelin expression in vivo, we might expect its level of expression to change during glial cell development. Thus far we have examined ~, expression in oligodendrocytes only over a limited period (13-21 d) without detecting a significant change in mRNA level. However, changes in /31 mRNA expression could occur earlier than day 13 or alternatively, the expression of the a chain may be regulated.
We are now in the process of determining the integrinmediated signaling events that regulate myelin synthesis. The matrix target of the oligodendrocyte integrin also remains an important issue. Despite continued efforts, the biochemical nature of the AGM ligand recognized by the oligodendrocyte integrin is still unknown. Antibodies to several known ECM proteins including fibronectin, laminin, tenascin, and vitronectin failed to inhibit oligodendrocytes adhesion to AGM (Cardwell and Rome, 1988a ; Malek-Hedayat, S., and L. H. Rome, unpublished observations). However, the AGM ligand appears to be highly insoluble since the adhesive activity can not be removed from AGM by strong detergents, chaotropic agents, high salt, or low pH (Hamilton, S. P., and L. H. Rome, unpublished observations). It is possible that the AGM ligand recognized by the oligodendrocyte integrin described here is a novel ECM component. In light of our preliminary results with anti-as antibody, it is intriguing that the identity of ligand(s) for us-containing integrins is still unknown (Bossy et al., 1991) .
